1. Home
  2. EVO vs NTCT Comparison

EVO vs NTCT Comparison

Compare EVO & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • NTCT
  • Stock Information
  • Founded
  • EVO 1993
  • NTCT 1984
  • Country
  • EVO Germany
  • NTCT United States
  • Employees
  • EVO N/A
  • NTCT N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • NTCT EDP Services
  • Sector
  • EVO Health Care
  • NTCT Technology
  • Exchange
  • EVO Nasdaq
  • NTCT Nasdaq
  • Market Cap
  • EVO 1.6B
  • NTCT 1.7B
  • IPO Year
  • EVO 2021
  • NTCT 1999
  • Fundamental
  • Price
  • EVO $3.60
  • NTCT $19.84
  • Analyst Decision
  • EVO Buy
  • NTCT Hold
  • Analyst Count
  • EVO 2
  • NTCT 1
  • Target Price
  • EVO $5.90
  • NTCT $25.00
  • AVG Volume (30 Days)
  • EVO 101.3K
  • NTCT 544.7K
  • Earning Date
  • EVO 04-17-2025
  • NTCT 05-08-2025
  • Dividend Yield
  • EVO N/A
  • NTCT N/A
  • EPS Growth
  • EVO N/A
  • NTCT N/A
  • EPS
  • EVO N/A
  • NTCT N/A
  • Revenue
  • EVO $825,103,013.00
  • NTCT $821,135,000.00
  • Revenue This Year
  • EVO $3.70
  • NTCT $0.22
  • Revenue Next Year
  • EVO $10.32
  • NTCT $2.04
  • P/E Ratio
  • EVO N/A
  • NTCT N/A
  • Revenue Growth
  • EVO 1.99
  • NTCT N/A
  • 52 Week Low
  • EVO $2.84
  • NTCT $17.10
  • 52 Week High
  • EVO $7.77
  • NTCT $27.89
  • Technical
  • Relative Strength Index (RSI)
  • EVO 56.15
  • NTCT 39.59
  • Support Level
  • EVO $3.27
  • NTCT $19.73
  • Resistance Level
  • EVO $3.40
  • NTCT $20.69
  • Average True Range (ATR)
  • EVO 0.14
  • NTCT 0.83
  • MACD
  • EVO 0.07
  • NTCT 0.02
  • Stochastic Oscillator
  • EVO 84.44
  • NTCT 49.28

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

Share on Social Networks: